X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-07-10 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $51.16 | -30,000 | 520,757 | -5% | -$1,534,895 | ||||||
| D | 2025-07-07 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $51.09 | -12,500 | 167,124 | -7% | -$638,661 | |||||
2025-07-01 | AKRO | Lamy Patrick | SVP, Commercial Strategy | S - Sale | $52.88 | -2,000 | 29,891 | -6% | -$105,760 | ||||||
2025-06-18 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $54.84 | -6,620 | 549,867 | -1% | -$363,041 | ||||||
2025-06-18 | AKRO | Gangloff Scott A. | CTO | S - Sale | $54.84 | -848 | 23,452 | -3% | -$46,504 | ||||||
2025-06-20 | AKRO | Lamy Patrick | SVP, Commercial Strategy | S - Sale | $54.59 | -875 | 31,698 | -3% | -$47,766 | ||||||
2025-06-18 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $54.84 | -1,129 | 166,234 | -1% | -$61,914 | ||||||
2025-06-18 | AKRO | White William Richard | CFO | S - Sale | $54.84 | -1,634 | 57,521 | -3% | -$89,609 | ||||||
2025-06-18 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $54.84 | -1,633 | 90,598 | -2% | -$89,554 | ||||||
2025-06-18 | AKRO | Young Jonathan | COO | S - Sale | $54.84 | -1,453 | 256,594 | -1% | -$79,683 | ||||||
| D | 2025-06-16 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $54.23 | -10,000 | 92,231 | -10% | -$542,306 | |||||
| D | 2025-06-16 | AKRO | Lamy Patrick | SVP, Commercial Strategy | S - Sale+OE | $54.14 | -2,000 | 32,573 | -6% | -$108,272 | |||||
2025-06-10 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $54.05 | -37,837 | 556,487 | -6% | -$2,044,940 | ||||||
2025-06-10 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $54.00 | -2,358 | 167,363 | -1% | -$127,323 | ||||||
2025-06-10 | AKRO | White William Richard | CFO | S - Sale | $54.00 | -2,804 | 59,155 | -5% | -$151,402 | ||||||
2025-06-10 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $54.00 | -2,803 | 92,231 | -3% | -$151,351 | ||||||
2025-06-10 | AKRO | Lamy Patrick | SVP, Commercial Strategy | S - Sale | $54.00 | -919 | 32,573 | -3% | -$49,625 | ||||||
2025-06-10 | AKRO | Young Jonathan | COO | S - Sale | $53.99 | -2,493 | 258,047 | -1% | -$134,605 | ||||||
| DM | 2025-06-05 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $54.52 | -37,500 | 169,721 | -18% | -$2,044,634 | |||||
| D | 2025-06-02 | AKRO | Lamy Patrick | SVP, Commercial Strategy | S - Sale+OE | $50.31 | -4,000 | 33,492 | -11% | -$201,258 | |||||
| D | 2025-05-22 | AKRO | Lamy Patrick | SVP, Commercial Strategy | S - Sale+OE | $50.00 | -4,000 | 33,492 | -11% | -$200,000 | |||||
| D | 2025-05-15 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $39.30 | -10,000 | 95,034 | -10% | -$392,978 | |||||
2025-05-12 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $41.48 | -30,000 | 594,324 | -5% | -$1,244,455 | ||||||
| D | 2025-05-07 | AKRO | Lamy Patrick | SVP, Commercial Strategy | S - Sale+OE | $42.49 | -8,000 | 33,492 | -19% | -$339,950 | |||||
| D | 2025-05-06 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $43.43 | -12,500 | 169,721 | -7% | -$542,864 | |||||
| D | 2025-04-24 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $41.03 | -6,250 | 169,721 | -4% | -$256,438 | |||||
| D | 2025-04-15 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $37.91 | -9,073 | 95,034 | -9% | -$343,962 | |||||
2025-04-10 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $35.23 | -30,000 | 624,324 | -5% | -$1,056,780 | ||||||
| D | 2025-04-07 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $35.88 | -6,250 | 169,721 | -4% | -$224,262 | |||||
| M | 2025-03-25 | AKRO | Graham G. Walmsley | Dir | P - Purchase | $43.94 | +200,000 | 1,202,168 | +20% | +$8,787,921 | |||||
| D | 2025-03-17 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $44.76 | -10,000 | 95,034 | -10% | -$447,605 | |||||
2025-03-12 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $44.88 | -1,738 | 654,324 | 0% | -$78,001 | ||||||
2025-03-12 | AKRO | Young Jonathan | COO | S - Sale | $44.88 | -607 | 260,540 | 0% | -$27,242 | ||||||
2025-03-12 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $44.88 | -614 | 95,034 | -1% | -$27,556 | ||||||
2025-03-12 | AKRO | White William Richard | CFO | S - Sale | $44.88 | -676 | 61,959 | -1% | -$30,339 | ||||||
2025-03-12 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $44.88 | -516 | 169,721 | 0% | -$23,158 | ||||||
2025-03-10 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $41.77 | -30,000 | 656,062 | -4% | -$1,253,069 | ||||||
| D | 2025-03-05 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $44.53 | -12,500 | 170,237 | -7% | -$556,590 | |||||
2025-03-04 | AKRO | Young Jonathan | COO | S - Sale | $44.86 | -50,000 | 261,147 | -16% | -$2,243,213 | ||||||
| D | 2025-03-03 | AKRO | Lamy Patrick | SVP, Commercial Strategy | S - Sale+OE | $48.09 | -1,000 | 33,492 | -3% | -$48,090 | |||||
| D | 2025-02-18 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $49.87 | -10,000 | 95,648 | -9% | -$498,660 | |||||
2025-02-10 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $52.73 | -30,000 | 686,062 | -4% | -$1,581,994 | ||||||
2025-01-30 | AKRO | Graham G. Walmsley | Dir | P - Purchase | $48.00 | +200,000 | 1,002,168 | +25% | +$9,600,000 | ||||||
| D | 2025-02-05 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $56.51 | -18,750 | 170,237 | -10% | -$1,059,630 | |||||
2025-02-03 | AKRO | Young Jonathan | COO | S - Sale | $53.81 | -10,000 | 311,147 | -3% | -$538,061 | ||||||
| D | 2025-01-27 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $56.25 | -53,590 | 95,648 | -36% | -$3,014,216 | |||||
| D | 2025-01-27 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $55.72 | -49,074 | 95,648 | -34% | -$2,734,212 | |||||
| D | 2025-01-27 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $55.77 | -31,250 | 170,237 | -16% | -$1,742,958 | |||||
| D | 2025-01-27 | AKRO | Lamy Patrick | SVP, Commercial Strategy | S - Sale+OE | $57.03 | -5,000 | 33,492 | -13% | -$285,150 | |||||
2025-01-27 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $54.90 | -30,000 | 716,062 | -4% | -$1,646,978 | ||||||
2025-01-02 | AKRO | Young Jonathan | COO | S - Sale | $28.03 | -10,000 | 278,083 | -3% | -$280,330 | ||||||
| D | 2024-12-16 | AKRO | Lamy Patrick | SVP, Commercial Strategy | S - Sale+OE | $29.13 | -1,000 | 34,258 | -3% | -$29,130 | |||||
| D | 2024-12-16 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $29.11 | -9,074 | 95,648 | -9% | -$264,117 | |||||
| D | 2024-12-17 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $31.10 | -3,800 | 198,337 | -2% | -$118,172 | |||||
| D | 2024-12-10 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $30.91 | -4,818 | 178,337 | -3% | -$148,934 | |||||
2024-12-10 | AKRO | Young Jonathan | COO | S - Sale | $30.79 | -2,503 | 263,783 | -1% | -$77,067 | ||||||
2024-12-10 | AKRO | Lamy Patrick | SVP, Commercial Strategy | S - Sale | $30.79 | -925 | 17,858 | -5% | -$28,481 | ||||||
2024-12-10 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $30.79 | -2,810 | 71,348 | -4% | -$86,520 | ||||||
2024-12-10 | AKRO | White William Richard | CFO | S - Sale | $30.79 | -2,817 | 38,335 | -7% | -$86,735 | ||||||
2024-12-10 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $30.79 | -7,855 | 597,562 | -1% | -$241,855 | ||||||
| D | 2024-12-02 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $32.09 | -25,000 | 605,417 | -4% | -$802,250 | |||||
2024-12-02 | AKRO | Young Jonathan | COO | S - Sale | $32.13 | -10,000 | 266,286 | -4% | -$321,310 | ||||||
| D | 2024-11-15 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $27.73 | -9,061 | 74,158 | -11% | -$251,274 | |||||
| D | 2024-11-06 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $35.19 | -10,000 | 74,158 | -12% | -$351,890 | |||||
| D | 2024-11-01 | AKRO | Young Jonathan | COO | S - Sale+OE | $31.57 | -50,716 | 276,286 | -16% | -$1,601,252 | |||||
| D | 2024-11-01 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $31.73 | -108,366 | 605,417 | -15% | -$3,438,312 | |||||
| DM | 2024-10-30 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $32.60 | -20,000 | 74,158 | -21% | -$651,960 | |||||
| DM | 2024-10-16 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $31.41 | -91,634 | 605,417 | -13% | -$2,878,038 | |||||
| D | 2024-10-14 | AKRO | Young Jonathan | COO | S - Sale+OE | $30.15 | -40,000 | 286,286 | -12% | -$1,206,080 | |||||
| DM | 2024-10-15 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $30.37 | -20,961 | 74,158 | -22% | -$636,490 | |||||
2024-10-01 | AKRO | Young Jonathan | COO | S - Sale | $28.18 | -10,000 | 286,286 | -3% | -$281,770 | ||||||
| D | 2024-09-20 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $27.65 | -5,500 | 75,294 | -7% | -$152,086 | |||||
| DM | 2024-09-16 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $27.54 | -8,393 | 75,294 | -10% | -$231,175 | |||||
2024-09-10 | AKRO | Young Jonathan | COO | S - Sale | $26.18 | -568 | 296,286 | 0% | -$14,870 | ||||||
2024-09-10 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $26.18 | -637 | 75,294 | -1% | -$16,677 | ||||||
2024-09-10 | AKRO | White William Richard | CFO | S - Sale | $26.18 | -639 | 41,152 | -2% | -$16,729 | ||||||
2024-09-10 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $26.18 | -537 | 180,705 | 0% | -$14,059 | ||||||
2024-09-10 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $26.18 | -1,738 | 605,417 | 0% | -$45,501 | ||||||
2024-09-03 | AKRO | Young Jonathan | COO | S - Sale | $26.72 | -5,000 | 296,854 | -2% | -$133,588 | ||||||
| D | 2024-09-03 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $27.61 | -949 | 75,931 | -1% | -$26,206 | |||||
| DM | 2024-08-26 | AKRO | White William Richard | CFO | S - Sale+OE | $27.02 | -98,334 | 41,791 | -70% | -$2,657,250 | |||||
| DM | 2024-08-23 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $27.52 | -14,051 | 75,931 | -16% | -$386,714 | |||||
2024-08-01 | AKRO | Young Jonathan | COO | S - Sale | $26.75 | -5,000 | 301,854 | -2% | -$133,756 | ||||||
| DM | 2024-07-23 | AKRO | White William Richard | CFO | S - Sale+OE | $27.07 | -161,855 | 41,791 | -79% | -$4,381,867 | |||||
| D | 2024-07-16 | AKRO | White William Richard | CFO | S - Sale+OE | $28.05 | -34,811 | 41,791 | -45% | -$976,274 | |||||
2024-07-01 | AKRO | Young Jonathan | COO | S - Sale | $23.40 | -5,000 | 306,854 | -2% | -$117,020 | ||||||
2024-06-11 | AKRO | Young Jonathan | COO | S - Sale | $22.64 | -2,516 | 310,790 | -1% | -$56,965 | ||||||
2024-06-11 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $22.64 | -2,825 | 74,867 | -4% | -$63,961 | ||||||
2024-06-11 | AKRO | White William Richard | CFO | S - Sale | $22.64 | -2,831 | 46,799 | -6% | -$64,094 | ||||||
2024-06-11 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $22.64 | -2,380 | 180,178 | -1% | -$53,886 | ||||||
2024-06-11 | AKRO | Lamy Patrick | SVP, Commercial Strategy | S - Sale | $22.64 | -569 | 18,562 | -3% | -$12,883 | ||||||
2024-06-11 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $22.64 | -7,894 | 581,553 | -1% | -$178,728 | ||||||
2024-06-03 | AKRO | Young Jonathan | COO | S - Sale | $19.29 | -5,000 | 313,306 | -2% | -$96,440 | ||||||
2024-05-01 | AKRO | Young Jonathan | COO | S - Sale | $20.15 | -5,000 | 318,306 | -2% | -$100,750 | ||||||
2024-04-01 | AKRO | Young Jonathan | COO | S - Sale | $24.38 | -5,000 | 587,012 | -1% | -$121,913 | ||||||
2024-03-13 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $28.33 | -723 | 77,692 | -1% | -$20,483 | ||||||
2024-03-13 | AKRO | White William Richard | CFO | S - Sale | $28.33 | -724 | 49,630 | -1% | -$20,511 | ||||||
2024-03-13 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $28.33 | -1,969 | 589,447 | 0% | -$55,782 | ||||||
2024-03-13 | AKRO | Young Jonathan | COO | S - Sale | $28.33 | -651 | 328,306 | 0% | -$18,443 | ||||||
2024-03-13 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $28.33 | -619 | 182,558 | 0% | -$17,536 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |